{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:00:33Z","timestamp":1793379633761,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1008312","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000}}],"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1008312","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T18:40:46Z","timestamp":1582051246000},"page":"e1008312","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":58,"title":["TNF-\u03b1 antagonists differentially induce TGF-\u03b21-dependent resuscitation of dormant-like Mycobacterium tuberculosis"],"prefix":"10.1371","volume":"16","author":[{"given":"Ainhoa","family":"Arbu\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Brees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah-Dine","family":"Chibout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2193-8076","authenticated-orcid":true,"given":"Michael","family":"Kamm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2949-9557","authenticated-orcid":true,"given":"Damien","family":"Portevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"issue":"1645","key":"ppat.1008312.ref001","doi-asserted-by":"crossref","first-page":"20130437","DOI":"10.1098\/rstb.2013.0437","article-title":"The ongoing challenge of latent tuberculosis","volume":"369","author":"H Esmail","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ppat.1008312.ref002","doi-asserted-by":"crossref","first-page":"k2738","DOI":"10.1136\/bmj.k2738","article-title":"Revisiting the timetable of tuberculosis","volume":"362","author":"MA Behr","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"ppat.1008312.ref003","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1574-6976.2012.00331.x","article-title":"Mycobacterium tuberculosis: Success through dormancy","volume":"36","author":"M Gengenbacher","year":"2012","journal-title":"FEMS microbiology reviews"},{"issue":"5","key":"ppat.1008312.ref004","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.20151248","article-title":"Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo","volume":"213","author":"Y Liu","year":"2016","journal-title":"The Journal of experimental medicine"},{"key":"ppat.1008312.ref005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tube.2016.05.006","article-title":"Defining dormancy in mycobacterial disease","volume":"99","author":"S Lipworth","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"issue":"2","key":"ppat.1008312.ref006","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tim.2017.08.001","article-title":"Opening Pandora's Box: Mechanisms of Mycobacterium tuberculosis Resuscitation","volume":"26","author":"AV Veatch","year":"2018","journal-title":"Trends Microbiol"},{"issue":"3","key":"ppat.1008312.ref007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.micinf.2016.10.001","article-title":"3rd, Wilkinson RJ, Wilkinson KA. The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition","volume":"19","author":"G Prosser","year":"2017","journal-title":"Microbes Infect"},{"issue":"Suppl 2","key":"ppat.1008312.ref008","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.cmi.2017.12.025","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (Soluble immune effector molecules I: anti-tumor necrosis factor-\u03b1 agents)","volume":"24","author":"JW Baddley","year":"2018","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"6","key":"ppat.1008312.ref009","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","article-title":"Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice","volume":"2","author":"JL Flynn","year":"1995","journal-title":"Immunity"},{"issue":"2","key":"ppat.1008312.ref010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.27271","article-title":"Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model","volume":"62","author":"PL Lin","year":"2010","journal-title":"Arthritis and rheumatism"},{"issue":"7","key":"ppat.1008312.ref011","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0192-0561(90)90034-K","article-title":"Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages","volume":"12","author":"M Denis","year":"1990","journal-title":"International journal of immunopharmacology"},{"issue":"2","key":"ppat.1008312.ref012","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4049\/jimmunol.152.2.743","article-title":"Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages","volume":"152","author":"CS Hirsch","year":"1994","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"9","key":"ppat.1008312.ref013","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","article-title":"TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection","volume":"168","author":"DR Roach","year":"2002","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"4","key":"ppat.1008312.ref014","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","article-title":"TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants\u2014past, present and future","volume":"25","author":"LM Sedger","year":"2014","journal-title":"Cytokine & growth factor reviews"},{"issue":"7","key":"ppat.1008312.ref015","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","article-title":"Transmembrane TNF-alpha: Structure, function and interaction with anti-TNF agents","volume":"49","author":"T Horiuchi","year":"2010","journal-title":"Rheumatology (Oxford, England)"},{"issue":"15","key":"ppat.1008312.ref016","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"J Keane","year":"2001","journal-title":"The New England journal of medicine"},{"key":"ppat.1008312.ref017","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3899\/jrheum.140103","article-title":"Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-\u03b1 (TNF-\u03b1) targeted biologics and recently licensed TNF-\u03b1 inhibitors: Data from clinical trials and national registries","volume":"91","author":"F Cantini","year":"2014","journal-title":"The Journal of rheumatology Supplement"},{"issue":"2","key":"ppat.1008312.ref018","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2004.11.060","article-title":"Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-\u03b1","volume":"128","author":"H Mitoma","year":"2005","journal-title":"Gastroenterology"},{"issue":"2","key":"ppat.1008312.ref019","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists","volume":"301","author":"B Scallon","year":"2002","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"issue":"1","key":"ppat.1008312.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04146.x","article-title":"How tumour necrosis factor blockers interfere with tuberculosis immunity","volume":"161","author":"J Harris","year":"2010","journal-title":"Clinical and experimental immunology"},{"issue":"12","key":"ppat.1008312.ref021","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1086\/593174","article-title":"Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis","volume":"198","author":"J Harris","year":"2008","journal-title":"The Journal of infectious diseases"},{"issue":"4","key":"ppat.1008312.ref022","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar1994","article-title":"Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists","volume":"8","author":"H Hamdi","year":"2006","journal-title":"Arthritis research & therapy"},{"issue":"10","key":"ppat.1008312.ref023","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1371\/journal.pcbi.0030194","article-title":"Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue","volume":"3","author":"S Marino","year":"2007","journal-title":"PLoS computational biology"},{"issue":"7","key":"ppat.1008312.ref024","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.4049\/jimmunol.1103298","article-title":"Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability","volume":"188","author":"M Fallahi-Sichani","year":"2012","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"4","key":"ppat.1008312.ref025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ccm.2019.07.003","article-title":"Tuberculosis and Biologic Therapies: Anti-Tumor Necrosis Factor-alpha and Beyond","volume":"40","author":"MS Godfrey","year":"2019","journal-title":"Clin Chest Med"},{"issue":"2","key":"ppat.1008312.ref026","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.icb.7100019","article-title":"An in vitro model of the leukocyte interactions associated with granuloma formation in Mycobacterium tuberculosis infection","volume":"85","author":"KA Birkness","year":"2007","journal-title":"Immunology and cell biology"},{"issue":"11","key":"ppat.1008312.ref027","doi-asserted-by":"crossref","first-page":"e1000204","DOI":"10.1371\/journal.ppat.1000204","article-title":"Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence","volume":"4","author":"P Peyron","year":"2008","journal-title":"PLoS pathogens"},{"issue":"1","key":"ppat.1008312.ref028","doi-asserted-by":"crossref","first-page":"e53657","DOI":"10.1371\/journal.pone.0053657","article-title":"Human granuloma in vitro model, for TB dormancy and resuscitation","volume":"8","author":"N Kapoor","year":"2013","journal-title":"PloS one"},{"issue":"1","key":"ppat.1008312.ref029","doi-asserted-by":"crossref","first-page":"e02537","DOI":"10.1128\/mBio.02537-14","article-title":"Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model","volume":"6","author":"E Guirado","year":"2015","journal-title":"mBio"},{"key":"ppat.1008312.ref030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tube.2016.07.009","article-title":"Dissecting host factors that regulate the early stages of tuberculosis infection","volume":"100","author":"N Agrawal","year":"2016","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"issue":"6","key":"ppat.1008312.ref031","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/JCM.42.6.2379-2387.2004","article-title":"Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection","volume":"42","author":"I Brock","year":"2004","journal-title":"Journal of clinical microbiology"},{"issue":"2","key":"ppat.1008312.ref032","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jinf.2015.10.012","article-title":"Population tailored modification of tuberculosis specific interferon-gamma release assay","volume":"72","author":"K Horvati","year":"2016","journal-title":"The Journal of infection"},{"issue":"1","key":"ppat.1008312.ref033","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","article-title":"Specific detection of tuberculosis infection: An interferon-gamma-based assay using new antigens","volume":"170","author":"T Mori","year":"2004","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"4","key":"ppat.1008312.ref034","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1371\/journal.pmed.0050075","article-title":"Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum","volume":"5","author":"NJ Garton","year":"2008","journal-title":"PLoS Med"},{"issue":"8","key":"ppat.1008312.ref035","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1038\/cti.2017.34","article-title":"Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections","volume":"6","author":"M Kamm\u00fcller","year":"2017","journal-title":"Clinical & translational immunology"},{"issue":"7","key":"ppat.1008312.ref036","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry","volume":"60","author":"F Tubach","year":"2009","journal-title":"Arthritis and rheumatism"},{"issue":"10","key":"ppat.1008312.ref037","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(08)70227-5","article-title":"Tumour necrosis factor antagonists: Structure, function, and tuberculosis risks","volume":"8","author":"RS Wallis","year":"2008","journal-title":"The Lancet Infectious Diseases"},{"issue":"3","key":"ppat.1008312.ref038","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4049\/jimmunol.1501573","article-title":"Transmembrane TNF-\u03b1 Reverse Signaling Inhibits Lipopolysaccharide-Induced Proinflammatory Cytokine Formation in Macrophages by Inducing TGF-\u03b2: Therapeutic Implications","volume":"196","author":"A Pallai","year":"2016","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"3","key":"ppat.1008312.ref039","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/MMBR.00010-14","article-title":"Latent tuberculosis infection: Myths, models, and molecular mechanisms","volume":"78","author":"NK Dutta","year":"2014","journal-title":"Microbiology and molecular biology reviews: MMBR"},{"key":"ppat.1008312.ref040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"A O'Garra","year":"2013","journal-title":"Annual review of immunology"},{"issue":"2","key":"ppat.1008312.ref041","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/annrheumdis-2017-211555","article-title":"Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?","volume":"77","author":"KF Baker","year":"2018","journal-title":"Annals of the rheumatic diseases"},{"issue":"11","key":"ppat.1008312.ref042","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1759720X17735756","article-title":"Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness","volume":"9","author":"YC Tsai","year":"2017","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"9","key":"ppat.1008312.ref043","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamadermatol.2015.0718","article-title":"Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)","volume":"151","author":"RE Kalb","year":"2015","journal-title":"JAMA dermatology"},{"issue":"12","key":"ppat.1008312.ref044","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/cid\/ciu185","article-title":"Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: A meta-analysis. Clinical infectious diseases: an official publication of the","volume":"58","author":"IS Kourbeti","year":"2014","journal-title":"Infectious Diseases Society of America"},{"issue":"5","key":"ppat.1008312.ref045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/14740338.2019.1612872","article-title":"Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice","volume":"18","author":"F Cantini","year":"2019","journal-title":"Expert opinion on drug safety"},{"issue":"1","key":"ppat.1008312.ref046","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaci.2015.10.023","article-title":"Alterations in immune function with biologic therapies for autoimmune disease","volume":"137","author":"M Her","year":"2016","journal-title":"The Journal of allergy and clinical immunology"},{"issue":"2","key":"ppat.1008312.ref047","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/clin.1998.4528","article-title":"The role of TGF beta in the pathogenesis of human tuberculosis","volume":"87","author":"Z Toossi","year":"1998","journal-title":"Clinical immunology and immunopathology"},{"issue":"5","key":"ppat.1008312.ref048","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/infdis\/170.5.1229","article-title":"Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1","volume":"170","author":"CS Hirsch","year":"1994","journal-title":"The Journal of infectious diseases"},{"issue":"8","key":"ppat.1008312.ref049","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1073\/pnas.94.8.3926","article-title":"In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta","volume":"94","author":"CS Hirsch","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"ppat.1008312.ref050","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI38482","article-title":"Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans","volume":"119","author":"H Bruns","year":"2009","journal-title":"J Clin Invest"},{"key":"ppat.1008312.ref051","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3389\/fimmu.2017.01843","article-title":"Deletion of TGF-\u03b21 Increases Bacterial Clearance by Cytotoxic T Cells in a Tuberculosis Granuloma Model","volume":"8","author":"HC Warsinske","year":"2017","journal-title":"Frontiers in immunology"},{"issue":"6","key":"ppat.1008312.ref052","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.4049\/jimmunol.162.6.3504","article-title":"Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin","volume":"162","author":"AG Bean","year":"1999","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"6","key":"ppat.1008312.ref053","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/1521-4141(200106)31:6<1935::AID-IMMU1935>3.0.CO;2-N","article-title":"Differential effects of TNF and LTalpha in the host defense against M. bovis BCG","volume":"31","author":"M Bopst","year":"2001","journal-title":"European journal of immunology"},{"issue":"2","key":"ppat.1008312.ref054","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1084\/jem.193.2.239","article-title":"Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection","volume":"193","author":"DR Roach","year":"2001","journal-title":"The Journal of experimental medicine"},{"issue":"7","key":"ppat.1008312.ref055","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.4049\/jimmunol.1000650","article-title":"Limited role for lymphotoxin \u03b1 in the host immune response to Mycobacterium tuberculosis","volume":"185","author":"N Allie","year":"2010","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"2","key":"ppat.1008312.ref056","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1189\/jlb.71.2.271","article-title":"Lima MRDI. Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile","volume":"71","author":"KRB Bastos","year":"2002","journal-title":"Journal of leukocyte biology"},{"issue":"6","key":"ppat.1008312.ref057","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity","volume":"26","author":"J Bustamante","year":"2014","journal-title":"Seminars in immunology"},{"issue":"3","key":"ppat.1008312.ref058","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jdcr.2017.02.001","article-title":"Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis","volume":"3","author":"M Lynch","year":"2017","journal-title":"JAAD case reports"},{"issue":"2","key":"ppat.1008312.ref059","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2133.2012.11162.x","article-title":"A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial","volume":"168","author":"T-F Tsai","year":"2013","journal-title":"The British journal of dermatology"},{"issue":"2","key":"ppat.1008312.ref060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.1601340","article-title":"T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection","volume":"199","author":"L Moreira-Teixeira","year":"2017","journal-title":"J Immunol"},{"issue":"1","key":"ppat.1008312.ref061","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/iid3.9","article-title":"Relative contribution of IL-1\u03b1, IL-1\u03b2 and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG","volume":"1","author":"M-L Bourigault","year":"2013","journal-title":"Immunity, inflammation and disease"},{"issue":"3","key":"ppat.1008312.ref062","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1086\/315771","article-title":"Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis","volume":"182","author":"NP Juffermans","year":"2000","journal-title":"The Journal of infectious diseases"},{"issue":"4","key":"ppat.1008312.ref063","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/RHU.0b013e31812e00a1","article-title":"Reactivation of pulmonary tuberculosis in a patient with rheumatoid arthritis during treatment with IL-1 receptor antagonists (anakinra)","volume":"13","author":"LD Settas","year":"2007","journal-title":"J Clin Rheumatol"},{"issue":"7507","key":"ppat.1008312.ref064","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature13489","article-title":"Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk","volume":"511","author":"KD Mayer-Barber","year":"2014","journal-title":"Nature"},{"issue":"2","key":"ppat.1008312.ref065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/imm.12130","article-title":"Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infection","volume":"140","author":"D Freches","year":"2013","journal-title":"Immunology"},{"issue":"10","key":"ppat.1008312.ref066","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.1101377","article-title":"IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung","volume":"187","author":"SA Khader","year":"2011","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"12","key":"ppat.1008312.ref067","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/infdis\/jiz020","article-title":"In Vitro Granuloma Models of Tuberculosis: Potential and Challenges","volume":"219","author":"P Elkington","year":"2019","journal-title":"J Infect Dis"},{"key":"ppat.1008312.ref068","doi-asserted-by":"crossref","first-page":"36923","DOI":"10.1038\/srep36923","article-title":"Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFalpha neutralization","volume":"6","author":"N Segueni","year":"2016","journal-title":"Sci Rep"},{"key":"ppat.1008312.ref069","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fimmu.2017.00612","article-title":"Nature and Consequences of Biological Reductionism for the Immunological Study of Infectious Diseases","volume":"8","author":"AL Rivas","year":"2017","journal-title":"Frontiers in immunology"},{"issue":"6","key":"ppat.1008312.ref070","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.immuni.2015.11.016","article-title":"Interdependence between Interleukin-1 and Tumor Necrosis Factor Regulates TNF-Dependent Control of Mycobacterium tuberculosis Infection","volume":"43","author":"NC Di Paolo","year":"2015","journal-title":"Immunity"},{"key":"ppat.1008312.ref071","doi-asserted-by":"crossref","first-page":"8909834","DOI":"10.1155\/2017\/8909834","article-title":"Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics","volume":"2017","author":"F Cantini","year":"2017","journal-title":"Mediators of inflammation"},{"issue":"10","key":"ppat.1008312.ref072","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/resp.13346","article-title":"Latent tuberculosis infection: Opportunities and challenges","volume":"23","author":"CBE Chee","year":"2018","journal-title":"Respirology (Carlton, Vic)"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1008312","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T19:30:07Z","timestamp":1722454207000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008312"}},"subtitle":[],"editor":[{"given":"Thomas R.","family":"Hawn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":72,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1008312","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1008312","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]}}}